Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles


We identified constitutional truncating mutations of the BRCA1-interacting helicase BRIP1 in 9/1,212 individuals with breast cancer from BRCA1/BRCA2 mutation–negative families but in only 2/2,081 controls (P = 0.0030), and we estimate that BRIP1 mutations confer a relative risk of breast cancer of 2.0 (95% confidence interval = 1.2–3.2, P = 0.012). Biallelic BRIP1 mutations were recently shown to cause Fanconi anemia complementation group J. Thus, inactivating truncating mutations of BRIP1, similar to those in BRCA2, cause Fanconi anemia in biallelic carriers and confer susceptibility to breast cancer in monoallelic carriers.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Abridged pedigrees of nine breast cancer families with BRIP1 mutations.


  1. Antoniou, A.C. & Easton, D.F. Genet. Epidemiol. 21, 1–18 (2001).

    Article  CAS  Google Scholar 

  2. Cantor, S.B. et al. Cell 105, 149–160 (2001).

    Article  CAS  Google Scholar 

  3. Cantor, S. et al. Proc. Natl. Acad. Sci. USA 101, 2357–2362 (2004).

    Article  CAS  Google Scholar 

  4. Peng, M. et al. Oncogene 25, 2245–2253 (2006).

    Article  CAS  Google Scholar 

  5. Cantor, S.B. & Andreassen, P.R. Cell Cycle 5, 164–167 (2006).

    Article  CAS  Google Scholar 

  6. Meijers-Heijboer, H. et al. Nat. Genet. 31, 55–59 (2002).

    Article  CAS  Google Scholar 

  7. Renwick, A. et al. Nat. Genet. 38, 873–875 (2006).

    Article  CAS  Google Scholar 

  8. Levitus, M. et al. Nat. Genet. 37, 934–935 (2005).

    Article  CAS  Google Scholar 

  9. Levran, O. et al. Nat. Genet. 37, 931–933 (2005).

    Article  CAS  Google Scholar 

  10. Litman, R. et al. Cancer Cell 8, 255–265 (2005).

    Article  CAS  Google Scholar 

  11. Howlett, N.G. et al. Science 297, 606–609 (2002).

    Article  CAS  Google Scholar 

  12. Taniguchi, T. & D'Andrea, A.D. Blood 107, 4223–4233 (2006).

    Article  CAS  Google Scholar 

  13. Swift, M. et al. J. Natl. Cancer Inst. 65, 863–867 (1980).

    CAS  PubMed  Google Scholar 

  14. Seal, S. et al. Cancer Res. 63, 8596–8599 (2003).

    CAS  PubMed  Google Scholar 

  15. Reid, S. et al. J. Med. Genet. 42, 147–151 (2005).

    Article  CAS  Google Scholar 

Download references


We thank the participating families who were recruited to the study by the Familial Breast Cancer Collaboration (UK), which includes the following contributors: A. Ardern-Jones, J. Berg, A. Brady, N. Bradshaw, C. Brewer, G. Brice, B. Bullman, J. Campbell, B. Castle, R. Cetnarsryj, C. Chapman, C. Chu, N. Coates, T. Cole, R. Davidson, A. Donaldson, H. Dorkins, F. Douglas, D. Eccles, R. Eeles, F. Elmslie, D.G. Evans, S. Goff, S. Goodman, D. Goudie, J. Gray, L. Greenhalgh, H. Gregory, N. Haites, S.V. Hodgson, T. Homfray, R.S. Houlston, L. Izatt, L. Jeffers, V. Johnson-Roffey, F. Kavalier, C. Kirk, F. Lalloo, I. Locke, M. Longmuir, J. Mackay, A. Magee, S. Mansour, Z. Miedzybrodzka, J. Miller, P. Morrison, V. Murday, J. Paterson, M. Porteous, N. Rahman, M. Rogers, S. Rowe, S. Shanley, A. Saggar, G. Scott, L. Side, L. Snadden, M. Steel, M. Thomas and S. Thomas. We thank A. Hall and E. Mackie for coordination of sample collection. We are grateful for the support of the Daniel Faulkner Trust and the Geoffrey Berger Charitable Trust. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. P. Kelly is supported by a grant from the Breast Cancer Campaign. M.A., B.N. and A.E. are supported by US Army Medical Research and Material Command grant #W81XWH-05-1-0204. This research was supported by the Institute of Cancer Research and Cancer Research UK.

Author information

Authors and Affiliations




The study was designed by N.R. and M.R.S. The molecular analyses were performed by S.S., A.R., P.K., R.B., T.C., H.J., M.A. and K.S. under the direction of N.R. The statistical analyses were performed by D.T., A.E., B.N. and L.M. under the direction of D.F.E. The familial collections were initiated by G.E. and D.E. and were collected by the Breast Cancer Susceptibility Collaboration (UK). The manuscript was written by N.R. and M.R.S.

Corresponding author

Correspondence to Nazneen Rahman.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

Primers and PCR conditions for BRIP1 coding exons. (PDF 9 kb)

Supplementary Table 2

Nonsynonymous BRIP1 missense variants in breast cancer cases and controls. (PDF 8 kb)

Supplementary Methods (PDF 21 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Seal, S., Thompson, D., Renwick, A. et al. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38, 1239–1241 (2006).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing